Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
LSE:FAB
Price:
6 GBX
-5.88%
Market Closed
Updated:
May 31, 2023
ROE
Return on Equity
According to
Fusion Antibodies PLC's
latest financial reports the company's roe is -51%.
-50.8%
Current
-33.6%
Average
-2.8%
Industry
ROE History
Statistics
Return on Equity
Return on Equity
| 1 Year | 3 Years | 5 Years | |
|---|---|---|---|
| Average | -43.7% | -33.6% | -30.7% |
| Median | -50.8% | -28.5% | -24.8% |
| Min | -51.9% | -60.7% | -60.7% |
| Max | -28.5% | -11.3% | -11.3% |
History Chart
Return on Equity
Return on Equity
ROE Distribution
ROE Distribution
Life Sciences Tools & Services Industry
Life Sciences Tools & Services Industry
ROE Across Competitors
ROE Comparison
Fusion Antibodies PLC Competitors
Fusion Antibodies PLC Competitors
| Country | UK |
| Market Cap | 1.6M GBP |
| ROE |
-51%
|
| Country | US |
| Market Cap | 198B USD |
| ROE |
15%
|
| Country | US |
| Market Cap | 166B USD |
| ROE |
14%
|
| Country | CH |
| Market Cap | 42.3B CHF |
| ROE |
12%
|
| Country | KR |
| Market Cap | 55.4T KRW |
| ROE |
12%
|
| Country | US |
| Market Cap | 36.8B USD |
| ROE |
18%
|
| Country | US |
| Market Cap | 34.7B USD |
| ROE |
25%
|
| Country | US |
| Market Cap | 30.7B USD |
| ROE |
-51%
|
| Country | US |
| Market Cap | 29B USD |
| ROE |
2 951%
|
| Country | CN |
| Market Cap | 198B CNY |
| ROE |
21%
|
| Country | US |
| Market Cap | 25B USD |
| ROE |
22%
|
Profitability Report
View the profitability report to see the full profitability analysis for Fusion Antibodies PLC.
See Also
Similar Stocks
What is Return on Equity?
ROE is a metric of how well the company utilizes its equity and measures how many dollars of profit are generated for each dollar of shareholder's equity.
ROE
= Net Income
/ Equity
Sensibly Priced Quality
Significantly Undervalued
Magic Formula
High Growth
